TRUPANION, INC.
A financial results roundup covers multiple insurers and MGAs. MetLife reported Q2 net income of $705m and adjusted EPS $2.43. Prudential posted Q2 net income of $985m and record individual life sales. Corebridge reported a $16m net loss and merger approval. Palomar, Heritage, TWFG, Root, Trupanion and Clover Health also reported Q2 figures and guidance updates.
Trupanion (NASDAQ:TRUP) reported Q2 CY2026 results. Revenue rose 11.1% year on year to $392.9 million, exceeding Wall Street estimates by 0.8%, and GAAP profit was $0.16 per share, 41.2% above consensus. The stock rose 5.2% to $25.66 after the release, according to the article.
TRUPANION, INC. (TRUP) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex991q22026.htm EX-99.1 Document Exhibit 99.1 Trupanion Reports Second Quarter 2026 Results Authorizes Share Repurchase Program SEATTLE, WA. August 5, 2026 -- Trupanion , Inc. (Nasdaq: TRUP), a leading provider of medical insurance for cats and dogs, today announced fin
Over the past 7 days, alphai's AI scored 4 news stories mentioning TRUP (TRUPANION, INC.). Coverage has skewed bullish: 3 bullish, 1 neutral, and 0 bearish.
Recent TRUP coverage spans earnings, insider activity and market movers.
In the last 30 days, TRUP insiders filed 1 SEC Form 4 transaction — no purchases and 1 sale ($11K). The most active reporter was GALLAGHER JOHN R, Chief Operating Officer, with 1 filing. 100% of activity was filed under pre-arranged Rule 10b5-1 plans.
Capital return authorization and tighter guidance range support confidence in TRUP’s revenue trajectory.
Results beat on revenue and GAAP EPS, driving an immediate post-report stock jump.
The 8-K discloses a fresh earnings datapoint plus capital return authorization, which can shift near-term valuation and sentiment.
The article is an earnings preview with consensus expectations and recent performance context, not a new fundamental disclosure.
Highlights the valuation/competition tension, but lacks new company-specific actions or updated guidance.
alphai scores every news story that mentions TRUP with an AI model for sentiment and relevance, and aggregates insider trades from TRUPANION, INC.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
A financial results roundup covers multiple insurers and MGAs. MetLife reported Q2 net income of $705m and adjusted EPS $2.43. Prudential posted Q2 net income of $985m and record individual life sales. Corebridge reported a $16m net loss and merger approval. Palomar, Heritage, TWFG, Root, Trupanion and Clover Health also reported Q2 figures and guidance updates.
9 min readTrupanion (NASDAQ:TRUP) reported Q2 CY2026 results. Revenue rose 11.1% year on year to $392.9 million, exceeding Wall Street estimates by 0.8%, and GAAP profit was $0.16 per share, 41.2% above consensus. The stock rose 5.2% to $25.66 after the release, according to the article.
2 min readTRUPANION, INC. (TRUP) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex991q22026.htm EX-99.1 Document Exhibit 99.1 Trupanion Reports Second Quarter 2026 Results Authorizes Share Repurchase Program SEATTLE, WA. August 5, 2026 -- Trupanion , Inc. (Nasdaq: TRUP), a leading provider of medical insurance for cats and dogs, today announced fin
6 min readTrupanion (NASDAQ: TRUP) will report Q2 results Wednesday after the bell. The company previously beat revenue expectations with $384 million in revenue, up 12.3% year on year. For the upcoming quarter, analysts expect revenue growth of 10.2% year on year. TRUP is down 7.3% over the past month, with an average analyst price target of $37.25 versus $24.92.
3 min readA shortened week ended higher as chip stocks led gains, oil eased, and optimism rose on early U.S.-Iran peace talks. Fed Chair Kevin Warsh’s comments on less transparency briefly pressured indexes. SpaceX (SPCX) stayed >14% above its June 12 IPO price. Analysts also cited Amazon’s Project Leo, Palantir’s cloud growth, and Rocket Lab’s Nasdaq-100 addition.
6 min readTRUPANION, INC. (TRUP) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. trup-20260610 false 0001371285 0001371285 2026-06-15 2026-06-15 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): J
2 min readWEINRAUCH STEVE (EVP, North Am & Vet Strategy) sold 6,674 shares of TRUPANION, INC. (TRUP) at $22.00 ($0.15M total) on 2026-06-05.
1 min readGALLAGHER JOHN R (Chief Operating Officer) sold 3,603 shares of TRUPANION, INC. (TRUP) at $21.69 on 2026-05-28 under a Rule 10b5-1 trading plan.
2 min readTooth Margaret (CEO) sold 491 shares of TRUPANION, INC. (TRUP) at $21.86 on 2026-05-25.
1 min readQureshi Fawwad (Chief Financial Officer) sold 6,007 shares of TRUPANION, INC. (TRUP) at $22.17 ($0.13M total) on 2026-05-27 under a Rule 10b5-1 trading plan.
1 min read
